Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase IV, Randomised Study to Evaluate the Immune Responses of UK Adolescent Girls Receiving CervarixTM or GardasilTM Human Papillomavirus Vaccines

NCT00956553 is registered in ClinicalTrials.gov with Public Health England as lead sponsor.

NCT NCT00956553
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00956553 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase IV, Randomised Study to Evaluate the Immune Responses of UK Adolescent Girls Receiving CervarixTM or GardasilTM Human Papillomavirus Vaccines
Lead sponsor
Public Health England
Phase
Phase 4
Overall status
Completed
Start date
September 30, 2009
Completion date
September 30, 2013
Enrollment
400 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

hpv infections